Julia Carabajal v. HHS - Influenza, shoulder injuries related to vaccine administration (SIRVA) (2025)
Case summary [AI summaries can sometimes make mistakes]
On October 1, 2024, Julia Carabajal filed a petition seeking compensation after an influenza vaccine administered on November 3, 2022. She alleged shoulder injuries related to vaccine administration, residual effects lasting more than six months, and no prior civil recovery.
Respondent denied that Ms. Carabajal sustained a SIRVA Table injury, denied that the flu vaccine caused her alleged shoulder injury or any other injury, and denied that her current condition was a sequela of a vaccine-related injury.
The public decision and attached stipulation do not describe the onset of pain, treatment course, diagnostic testing, daily-life limitations, expert testimony, or biological mechanism. On October 8, 2025, Chief Special Master Brian H.
Corcoran found the stipulation reasonable and adopted it as the Court's decision. Ms.
Carabajal was awarded a lump sum of $88,000.00 through counsel's IOLTA account, representing all damages available under Section 15(a).
Theory of causation
Influenza vaccine, November 3, 2022, alleged shoulder injuries related to vaccine administration (SIRVA). COMPENSATED by stipulation. Respondent denied Table SIRVA, vaccine causation, and sequelae, but the parties resolved the claim. Public text gives no clinical onset, treatment, imaging, experts, or mechanism beyond the SIRVA allegation. Award: $88,000 lump sum for all Section 15(a) damages, ACH to counsel IOLTA. Chief Special Master Corcoran October 8, 2025. Attorney Bridget Candace McCullough, Muller Brazil; respondent Parisa Tabassian.
Source PDFs
USCOURTS-cofc-1_24-vv-01548